Baby Aspirin is Hope for Cancer Patients
We have all heard that one baby aspirin a day can help prevent a heart attack and people everywhere and from all walks of life subscribe to the commonly recommended protocol on a regular basis. Now there is even more evidence appearing on the horizon for expanded potential of that daily routine.
Though proof is still to come, three new studies, published by the British medical journal, The Lancet, are contributing to this hypothesis.
The Oxford University study found that those taking a small does (75 – 300 mg) daily of aspirin were at lower risk of a heart attack. Of that group, 23 percent, over a period of three years, were less likely to develop cancer than non-aspirin takers. Professor Peter Rothwell emphasized that bowel cancer in particular showed signs of reduced risk. When taken over five years, 37 percent of those in the study had a lower rate of total cancer. The longer patients stayed on aspirin the greater the decrease of the risk of death from cancer. In the aspirin taking group, of 1000 cases of cancer each year, there were nine cancer cases. That compares to the 12 per 1000 in the group taking a placebo.
















Email
Facebook
Twitter